LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 29.19 | 27.76 | 1108 | 1863 | 0.5947 | 0.8359 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 29.19 | 27.76 | 1148 | 1863 | 0.6162 | 0.8466 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 30.90 | 27.76 | 948 | 2032 | 0.4665 | 0.7683 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 30.90 | 27.76 | 978 | 2032 | 0.4812 | 0.7772 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 30.90 | 27.76 | 1082 | 2032 | 0.5324 | 0.8065 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 30.90 | 27.76 | 1114 | 2032 | 0.5481 | 0.8150 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.60 | 27.76 | 1055 | 2235 | 0.4719 | 0.7763 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.60 | 27.76 | 1095 | 2235 | 0.4898 | 0.7868 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.60 | 27.76 | 1086 | 2235 | 0.4857 | 0.7844 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 32.60 | 27.76 | 1113 | 2235 | 0.4978 | 0.7914 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.30 | 27.76 | 1107 | 2449 | 0.4519 | 0.7687 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.30 | 27.76 | 1140 | 2449 | 0.4654 | 0.7768 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.30 | 27.76 | 1203 | 2449 | 0.4911 | 0.7916 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 34.30 | 27.76 | 1232 | 2449 | 0.5029 | 0.7982 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.01 | 27.76 | 1033 | 2662 | 0.3879 | 0.7321 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.01 | 27.76 | 1067 | 2662 | 0.4007 | 0.7406 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.01 | 27.76 | 1143 | 2662 | 0.4292 | 0.7589 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.01 | 27.76 | 1169 | 2662 | 0.4390 | 0.7649 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.71 | 27.76 | 1058 | 2877 | 0.3677 | 0.7224 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.71 | 27.76 | 1088 | 2877 | 0.3781 | 0.7296 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.71 | 27.76 | 1204 | 2877 | 0.4184 | 0.7560 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 37.71 | 27.76 | 1225 | 2877 | 0.4257 | 0.7605 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 39.41 | 27.76 | 1087 | 3105 | 0.3500 | 0.7141 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 39.41 | 27.76 | 1117 | 3105 | 0.3597 | 0.7210 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 39.41 | 27.76 | 1134 | 3105 | 0.3651 | 0.7248 | MN20160318_Q01 | L05 |